Factors predictive of medication nonadherence after renal transplantation: A french observational study

Transplantation

Volumn 95, Issue 2, 2013, Pages 326-332

  Couzi, Lionel ^a,l   Moulin, Bruno ^b   Morin, Marie Pascale ^c   Albano, Laetitia ^d   Godin, Michel ^e   Barrou, Benoit ^f,g   Alamartine, Eric ^h   Morelon, Emmanuel ⁱ   Girardot Seguin, Sandrine ^j   Mendes, Laurence ^j   Misdrahi, David ^k   Cassuto, Elisabeth ^d   Merville, Pierre ^a  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^d PASTEUR HOSPITAL   (France)

^e Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g SORBONNE UNIVERSITÉ   (France)

^h UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

ⁱ EDOUARD HERRIOT HOSPITAL   (France)

^j Roche   (France)

^k CENTRE HOSPITALIER CHARLES PERRENS   (France)

^l HÔPITAL PELLEGRIN   (France)

more..

Author keywords

Adherence; Adverse events; Kidney transplantation; Medication regimen

Indexed keywords

CYCLOSPORIN; TACROLIMUS;

ADULT; AGE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FRANCE; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORISKY SCALE; OBSERVATIONAL STUDY; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHYSICIAN ATTITUDE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RATING SCALE; SELF REPORT; TREATMENT REFUSAL; UNSPECIFIED SIDE EFFECT;

ADULT; AGE FACTORS; ATTITUDE TO COMPUTERS; CHI-SQUARE DISTRIBUTION; COMPUTER-ASSISTED INSTRUCTION; FEMALE; FRANCE; GRAFT REJECTION; GRAFT SURVIVAL; HEALTH INFORMATION SYSTEMS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT EDUCATION AS TOPIC; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SOFTWARE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84872975549     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318271d7c1     Document Type: Article

References (43)

1. Fine RN, Becker Y, De Geest S, et al. Nonadherence consensus conference summary report. Am J Transplant 2009; 9: 35.
2. Butler JA, Roderick P, Mullee M, et al. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation 2004; 77: 769.
3. Denhaerynck K, Dobbels F, Cleemput I, et al. Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review. Transpl Int 2005; 18: 1121.
4. Bunzel B, Laederach-Hofmann K. Solid organ transplantation: are there predictors for posttransplant noncompliance? A literature overview. Transplantation 2000; 70: 711.
5. Vlaminck H, Maes B, Evers G, et al. Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients. Am J Transplant 2004; 4: 1509.
6. Hilbrands LB, Hoitsma AJ, Koene RA. Medication compliance after renal transplantation. Transplantation 1995; 60: 914.
7. De Geest S, Borgermans L, Gemoets H, et al. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation 1995; 59: 340.
8. Nevins TE, Kruse L, Skeans MA, et al. The natural history of azathioprine compliance after renal transplantation. Kidney Int 2001; 60: 1565.
9. Takemoto SK, Pinsky BW, Schnitzler MA, et al. A retrospective analysis of immunosuppression compliance, dose reduction and discontinuation in kidney transplant recipients. Am J Transplant 2007; 7: 2704.
10. Chisholm-Burns MA, Spivey CA, Rehfeld R, et al. Immunosuppressant therapy adherence and graft failure among pediatric renal transplant recipients. Am J Transplant 2009; 9: 2497.
11. Pinsky BW, Takemoto SK, Lentine KL, et al. Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant 2009; 9: 2597.
12. Dew MA, DiMartini AF, De Vito Dabbs A, et al. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation 2007; 83: 858.
13. Kiley DJ, Lam CS, Pollak R. A study of treatment compliance following kidney transplantation. Transplantation 1993; 55: 51.
14. Frazier PA, Davis-Ali SH, Dahl KE. Correlates of noncompliance among renal transplant recipients. Clin Transplant 1994; 8: 550.
15. Chapman Jr. Compliance: the patient, the doctor, and the medication? Transplantation 2004; 77: 782.
16. Weng FL, Israni AK, Joffe MM, et al. Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation. J Am Soc Nephrol 2005; 16: 1839.
17. Denhaerynck K, Steiger J, Bock A, et al. Prevalence and risk factors of non-adherence with immunosuppressive medication in kidney transplant patients. Am J Transplant 2007; 7: 108.
18. Dobbels F, Vanhaecke J, Dupont L, et al. Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation 2009; 87: 1497.
19. Greenstein S, Siegal B. Odds probabilities of compliance and noncompliance in patients with a functioning renal transplant: a multicenter study. Transplant Proc 1999; 31: 280.
20. Greenstein S, Siegal B. Compliance and noncompliance in patients with a functioning renal transplant: a multicenter study. Transplantation 1998; 66: 1718.
21. Axelrod DA, Millman D, Abecassis MM. US Health Care Reform and Transplantation, Part II: impact on the public sector and novel health care delivery systems. Am J Transplant 2010; 10: 2203.
22. Cohen DJ, Murphy B. Drug coverage for transplantation turns into political football: big business trumps patients. Clin J Am Soc Nephrol 2010; 5: 746.
23. Butkus DE, Meydrech EF, Raju SS. Racial differences in the survival of cadaveric renal allografts. Overriding effects of HLA matching and socioeconomic factors. N Engl J Med 1992; 327: 840.
24. Dew MA, Dimartini AF, De Vito Dabbs A, et al. Adherence to the medical regimen during the first two years after lung transplantation. Transplantation 2008; 85: 193.
25. Goldfarb-Rumyantzev AS, Koford JK, Baird BC, et al. Role of socioeconomic status in kidney transplant outcome. Clin J Am Soc Nephrol 2006; 1: 313.
26. Yen EF, Hardinger K, Brennan DC, et al. Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant. Am J Transplant 2004; 4: 1703.
27. Chisholm MA, Vollenweider LJ, Mulloy LL, et al. Renal transplant patient compliance with free immunosuppressive medications. Transplantation 2000; 70: 1240.
28. Schmid-Mohler G, Thut MP, Wuthrich RP, et al. Non-adherence to immunosuppressive medication in renal transplant recipients within the scope of the Integrative Model of Behavioral Prediction: a crosssectional study. Clin Transplant 2010; 24: 213.
29. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353: 487.
30. Butler JA, Peveler RC, Roderick P, et al. Modifiable risk factors for non-adherence to immunosuppressants in renal transplant recipients: a cross-sectional study. Nephrol Dial Transplant 2004; 19: 3144.
31. Kung M, Koschwanez HE, Painter L, et al. Immunosuppressant nonadherence in heart, liver, and lung transplant patients: associations with medication beliefs and illness perceptions. Transplantation 2012; 93: 958.
32. Ekberg H, Kyllonen L, Madsen S, et al. Clinicians underestimate gastrointestinal symptoms and overestimate quality of life in renal transplant recipients: a multinational survey of nephrologists. Transplantation 2007; 84: 1052.
33. Rosenberger J, Geckova AM, van Dijk JP, et al. Prevalence and characteristics of noncompliant behaviour and its risk factors in kidney transplant recipients. Transpl Int 2005; 18: 1072.
34. Schafer-Keller P, Dickenmann M, Berry DL, et al. Computerized patient education in kidney transplantation: testing the content validity and usability of the Organ Transplant Information System (OTIS). Patient Educ Couns 2009; 74: 110.
35. Couzi L. OTIS: a promising tool that needs to be evaluated in large studies. Patient Educ Couns 2009; 74: 132.
36. Denhaerynck K, Burkhalter F, Schafer-Keller P, et al. Clinical consequences of non adherence to immunosuppressive medication in kidney transplant patients. Transpl Int 2009; 22: 441.
37. Israni AK, Weng FL, Cen YY, et al. Electronically measured adherence to immunosuppressive medications and kidney function after deceased donor kidney transplantation. Clin Transplant 2011; 25: E124.
38. Dobbels F, Berben L, De Geest S, et al. The psychometric properties and practicability of self-report instruments to identify medication nonadherence in adult transplant patients: a systematic review. Transplantation 2010; 90: 205.
39. Schafer-Keller P, Steiger J, Bock A, et al. Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients. Am J Transplant 2008; 8: 616.
40. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24: 67.
41. Butler JA, Peveler RC, Roderick P, et al. Measuring compliance with drug regimens after renal transplantation: comparison of self-report and clinician rating with electronic monitoring. Transplantation 2004; 77: 786.
42. Snaith RP. The Hospital Anxiety and Depression Scale. Health Qual Life Outcomes 2003; 1: 29.
43. Misdrahi D, Verdoux H, Lancon C, et al. The 4-Point ordinal Alliance Self-report: a self-report questionnaire for assessing therapeutic relationships in routine mental health. Compr Psychiatry 2009; 50: 181.